These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31337753)

  • 21. Pharmacological HIF2α inhibition improves VHL disease-associated phenotypes in zebrafish model.
    Metelo AM; Noonan HR; Li X; Jin Y; Baker R; Kamentsky L; Zhang Y; van Rooijen E; Shin J; Carpenter AE; Yeh JR; Peterson RT; Iliopoulos O
    J Clin Invest; 2015 May; 125(5):1987-97. PubMed ID: 25866969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCTP increases stability of hypoxia-inducible factor 1α by interaction with and degradation of the tumour suppressor VHL.
    Chen K; Chen S; Huang C; Cheng H; Zhou R
    Biol Cell; 2013 May; 105(5):208-218. PubMed ID: 23387829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-mediated rescue of retinal ganglion cells deficient in mitochondrial complex I is independent of the hypoxia-inducible factor pathway.
    Warwick AM; Bomze HM; Wang L; Hao Y; Stinnett SS; Gospe SM
    Sci Rep; 2024 Oct; 14(1):24114. PubMed ID: 39406814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico investigation of PHD-3 specific HIF1-α proline 567 hydroxylation: a new player in the VHL/HIF-1α interaction pathway?
    Minervini G; Masiero A; Moro S; Tosatto SC
    FEBS Lett; 2013 Sep; 587(18):2996-3001. PubMed ID: 23886708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
    Gong K; Zhang N; Zhang K; Na Y
    Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.
    Wang J; Lu Z; Xu Z; Tian P; Miao H; Pan S; Song R; Sun X; Zhao B; Wang D; Ma Y; Song X; Zhang S; Liu L; Jiang H
    Sci Rep; 2017 Jan; 7():41038. PubMed ID: 28112200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homotypic association between tumour-associated VHL proteins leads to the restoration of HIF pathway.
    Chung J; Roberts AM; Chow J; Coady-Osberg N; Ohh M
    Oncogene; 2006 May; 25(21):3079-83. PubMed ID: 16407835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
    Liu N; Xia WY; Liu SS; Chen HY; Sun L; Liu MY; Li LF; Lu HM; Fu YJ; Wang P; Wu H; Gao JX
    Sci Rep; 2016 Feb; 6():20489. PubMed ID: 26841847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
    Kaelin WG
    Trans Am Clin Climatol Assoc; 2017; 128():298-307. PubMed ID: 28790514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.
    Cuperlovic-Culf M; Cormier K; Touaibia M; Reyjal J; Robichaud S; Belbraouet M; Turcotte S
    Int J Cancer; 2016 May; 138(10):2439-49. PubMed ID: 26620126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
    Mathia S; Paliege A; Koesters R; Peters H; Neumayer HH; Bachmann S; Rosenberger C
    Acta Physiol (Oxf); 2013 Mar; 207(3):565-76. PubMed ID: 23384425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma.
    Thompson JM; Nguyen QH; Singh M; Pavesic MW; Nesterenko I; Nelson LJ; Liao AC; Razorenova OV
    Oncogene; 2017 Feb; 36(8):1080-1089. PubMed ID: 27841867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptional regulation of genes via hypoxia-inducible factor.
    Roche O; Ohh M
    Methods Mol Biol; 2012; 809():189-99. PubMed ID: 22113277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Von Hippel-Lindau Protein Is Required for Optimal Alveolar Macrophage Terminal Differentiation, Self-Renewal, and Function.
    Izquierdo HM; Brandi P; Gómez MJ; Conde-Garrosa R; Priego E; Enamorado M; Martínez-Cano S; Sánchez I; Conejero L; Jimenez-Carretero D; Martín-Puig S; Guilliams M; Sancho D
    Cell Rep; 2018 Aug; 24(7):1738-1746. PubMed ID: 30110631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hif-2α promotes degradation of mammalian peroxisomes by selective autophagy.
    Walter KM; Schönenberger MJ; Trötzmüller M; Horn M; Elsässer HP; Moser AB; Lucas MS; Schwarz T; Gerber PA; Faust PL; Moch H; Köfeler HC; Krek W; Kovacs WJ
    Cell Metab; 2014 Nov; 20(5):882-897. PubMed ID: 25440060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An ID2-dependent mechanism for VHL inactivation in cancer.
    Lee SB; Frattini V; Bansal M; Castano AM; Sherman D; Hutchinson K; Bruce JN; Califano A; Liu G; Cardozo T; Iavarone A; Lasorella A
    Nature; 2016 Jan; 529(7585):172-7. PubMed ID: 26735018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice.
    Wang J; Ma Y; Jiang H; Zhu H; Liu L; Sun B; Pan S; Krissansen GW; Sun X
    J Hepatol; 2011 Aug; 55(2):359-68. PubMed ID: 21168458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells.
    Chiavarina B; Martinez-Outschoorn UE; Whitaker-Menezes D; Howell A; Tanowitz HB; Pestell RG; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Sep; 11(17):3280-9. PubMed ID: 22894905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.